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Background: Patients with hazardous alcohol intake are overrepresented in emergency departments and surgical
wards. These patients have an increased risk of postoperative complications with prolonged hospital stays and
admissions to intensive care unit after surgery. In elective surgery, preoperative alcohol cessation interventions can
reduce postoperative complications, but no studies have investigated the effect of alcohol cessation intervention at
the time of acute fracture surgery. This protocol describes a randomised clinical trial that aims to evaluate the effect
of a new gold standard programme for alcohol cessation intervention in the perioperative period regarding
postoperative complications, alcohol intake and cost-effectiveness.
Methods/Design: Patients with hazardous alcohol intake undergoing ankle fracture surgery will be recruited into
the trial from multiple orthopaedic wards at university hospitals in Denmark, Sweden and Norway. Included patients
will be randomly allocated to either standard care or the gold standard programme aimed at complete alcohol
abstinence before, during and 6 weeks after surgery. It includes a structured patient education programme and
weekly interventions meetings at the orthopaedic outpatient clinic. Furthermore, patients are provided with
thiamine and B-vitamins, alcohol withdrawal prophylaxis and treatment, and disulfiram to support abstinence.
Alcohol intake is biochemically validated (blood, urine and breath tests) at the weekly intervention meetings and
follow-up visits. Follow-up assessments will be conducted 6 weeks and 3, 6, 9 and 12 months after surgery for all
patients. The effect of the gold standard programme will be assessed comparing the outcome measures between
the intervention and control group at each follow-up point.
Discussion: The study will provide new knowledge about how to prevent alcohol-related postoperative complications
at the time of acute fracture surgery. If effective, the results will be a benefit for the clinical course, patients and
society alike.
Trial registration: The protocol is registered in ClinicalTrials.gov (Id: NCT00986791).
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Alcohol intake is an independent risk factor for postop-
erative complications after major and minor operations,
elective and emergency procedures for men and women
[1]. Patients with hazardous alcohol intake are therefore
at increased risk of general infections, wound and pul-
monary complications, prolonged hospital stay and admis-
sion to the intensive care unit after surgery compared to
abstainers or non-hazardous drinkers [2].
The poor surgical outcome is seen in patients with
hazardous alcohol intake – even without liver disease,
pancreatitis or other alcohol-related diseases [3]. The
responsible pathophysiological mechanisms include a var-
iety of subclinical dys-functioning organ systems, such as
sub-clinical cardiac dysfunction, prolonged bleeding time
and en extreme endocrine stress-response to the surgical
intervention per se [1,4,5].
The postoperative complication rate is about doubled
at an intake as low as > 2 drinks per day [6,7]. However,
most of these patients do not have diagnoses commonly
associated with alcohol misuse [8]. As all forms of excessive
drinking increases the risk of trauma and hospitalisation,
hazardous drinkers are overrepresented in emergency de-
partments (ED) and surgical wards [7,9].
Surgical patients as well as patient with trauma seem
very motivated to change their lifestyle including drink-
ing habits [10-12]. Reviews found that at least two in
three of these patients accept alcohol screening and two
in three accept participation in alcohol interventions
[13]. This period has been described as a ‘window of op-
portunity’, even though it may be very short. Furthermore,
one in three reduces their alcohol intake spontaneously,
when admitted to surgical wards [14].
Only three alcohol intervention studies have evaluated
the effect on postoperative complications in high quality
designs. Two randomised clinical trials (RCT) evaluated
4 and 8 weeks of preoperative intensive alcohol cessation
intervention for patients drinking 60 g of ethanol per day
or more aimed at reduction of postoperative complica-
tions. The intervention programme in both RCTs included
empowerment to support complete alcohol abstinence, in-
formation, weekly visits, and prophylaxis of withdrawal
symptoms and relapse with benzodiazepine and disulfiram
(DIS) [15]. The compliance was very high, and a recent
meta-analysis showed a significant effect on risk reduction
and alcohol intake [16]. In contrast, a controlled clinical
trial in general elective surgery could not show an effect of
brief intervention (BI) aiming at alcohol reduction on
postoperative complications [17]. BI consisting of feed-
back, information and advice have shown low or no effect
on alcohol intake over time in general hospital settings
and general practice [18-21]. Thus, the effect of BI on al-
cohol intake seems too small to have an effect on postop-
erative complications.A review of cost-effectiveness and cost-benefit studies
on screening and BI supported the use of alcohol screen-
ing and BI, though the effect was only minor [22]. In
trauma patients screening and BI for alcohol problems are
cost-effective regarding number of re-trauma [23].
No previous studies have investigated the effect on
complications and costs of intensive alcohol cessation
intervention at the time of acute surgery. A comprehen-
sive 6-weeks gold standard programme for alcohol ces-
sation intervention (GSP-A) was translated from the
previous preoperative alcohol cessation studies as well as
studies using the gold standard programme (GSP) [24]
for smoking cessation intervention in surgical settings
[25]. The GSP-A is also based on evidence from system-
atic reviews, results from a cross-sectional study on risk
factors in a hospital population and patient preferences
regarding alcohol intervention in relation to surgery
[13,16,26-30].
The aim of this study is to evaluate the effect of the
GSP-A aimed at 6 weeks complete alcohol abstinence in
the perioperative period for hazardous drinking patients
undergoing ankle fracture surgery regarding postopera-
tive complications, alcohol intake and cost-effectiveness
up to 12 months after surgery.
Methods/Design
Study design and setting
A randomised clinical multi-centre study will be conduc-
ted including adult (minimum 18 years) patients undergo-
ing ankle fracture surgery and drinking 21 or more drinks
(one drink equals 12 g ethanol) per week for at least 3
months before admission. Patients are consecutively re-
cruited from multiple orthopaedic wards at university hos-
pitals. The centres initially participating in the study are
Bispebjerg/Frederiksberg, Hvidovre and Southern Jutland
from Denmark, Lund from Sweden as well as Haukeland
and Stavager from Norway.
Included patients will be randomly allocated to either
the intervention group or control group (standard care).
Patients in the intervention group will receive the GSP-A
aimed at alcohol abstinence at the time of ankle fracture
surgery and 6 weeks after. It includes a structured patient
education programme and weekly interventions meetings
initially at the orthopaedic ward and continued after dis-
charge at the outpatient clinic (5 in total). Patients in the
control group will receive standard care for patients with
hazardous alcohol intake according to the clinical guide-
lines in the wards.
For both groups follow-up assessments will be conduc-
ted after 6 weeks and 3, 6, 9 and 12 months after surgery;
see trial profile in Figure 1. The primary outcomes are
postoperative complications requiring treatment, alcohol
intake (abstinence and non-hazardous drinking) as well as
cost-effectiveness. The effect of the GSP-A will be assessed
Figure 1 Trial profile.
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tion and control group at each follow-up point.
Recruitment process and inclusion criteria
All ankle fracture patients admitted to the orthopaedic
wards and scheduled for surgery are screened for eligibility
by the research staff, and patients fulfilling the inclusion,
but not the exclusion criteria, are invited to participate in
the trial. The inclusion criteria are traumatic ankle frac-
ture requiring internal fixation (osteosynthesis), informed
consent, and randomisation within 36 hours after entering
the orthopaedic ward. The fracture can be open or closed
as well as simple or comminuted. The exclusion criteria
are major trauma involving other fractures or major le-
sions, preoperative severe psychiatric disorders (including
drug addiction, severe alcohol dependence [defined as ex-
perience of delirium or seizures during abstinence from
alcohol] and dementia) or other conditions of reduced
ability for giving informed consent; pathological fractures,
pregnancy and lactation; allergy to benzodiazepines orDIS; uncompensated chronic diseases (including fulmin-
ant cardiac or liver insufficiency, which are contraindica-
tions for DIS) or ASA score 4-5 [31]; cancelled operation
and withdrawal of informed consent.
Patients are included after informed consent, which
can be obtained before or after the operation but within
the 36 hours after admission. The patients can withdraw
the informed consent at any time without any explan-
ation and without consequences for their treatment or
contact to the staff. For patients not giving or withdrawing
their informed consent research staff will ask permission
for follow-up via their medical recording solely for the
purpose of the project.
Randomisation, allocation concealment and sequence
generation
A computer-generated list of random numbers will be
used for allocation of the patients. The randomisation
sequence is created using www.sealedenvelope.com stat-
istical software, and is stratified by centre with a 1:1
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by a researcher not otherwise involved in the project and
prior to the commencement of recruitment. The allo-
cation sequence will be concealed from the research staff
enrolling and assessing participants in sequentially num-
bered, opaque, sealed and stapled envelops that are imper-
meable to intense light. Corresponding envelops will be
opened only after the patients have given informed con-
sent and it is time to allocate the intervention group.
Data collection
Baseline data will be collected for all included patients
during admission in interviews: A detailed alcohol pro-
file on intake over time (Timeline Follow-back [32]),
ICD-10 criteria for alcohol dependency [33], test for al-
cohol use disorders (AUDIT-C [34]), alcohol withdrawal
symptoms (CIWA-Ar [35]), breath test (ethanol during
expiration), blood sampling for liver function (haemoglobin,
alkaline phosphates, gamma-glyteryl-transferase, amino-
transferases, bilirubine) and for alcohol markers (carbohy-
drate-deficient transferring, ethanol, phosphatidylethanol,
mean cell volume, serum, EDTA–plasma and citrate-
plasma); urine sampling for alcohol markers (ethyl glucu-
ronide, ethyl sulphate, ethanol).
Furthermore, baseline characteristics regarding age and
sex, socio-demographic factors, other lifestyle factors
(smoking, overweight, risk of malnutrition and physical
inactivity [36]), co-morbidity, self-rated ankle function,
and self-evaluated health assessed in the SF-36 question-
naire [37] will be obtained for all patients.
During admission the following information will be
collected from the medical records: AO-classification of
the ankle fracture and surgical characteristics; ASA-score
[31], operative procedure, antibiotics and thrombo-embolic
prophylaxis, type of anaesthesia, blood loss, infusions, im-
plants and surgical or anaesthetic problems. Besides, length
of hospital stay, use of resources and medicines, discharge
or transfer will be registered for all patients.
Follow-up visits will be conducted after 6 weeks, 3, 6,
9 and 12 months in the orthopaedic outpatient clinics.
Patients will be evaluated on postoperative complications
and second surgery, Olerud-Molander Ankle Score [38],
dorsal plantar flexibility (after 3, 6, 9 and 12 months) and
fracture status after 12 months confirmed by x-ray (satis-
factory healing, secondary dislocation or non-union. Effect
on alcohol intake will be assessed by Timeline Follow-
back [32], alcohol withdrawal symptoms (CIWA-Ar [35]),
breath test (ethanol during expiration) as well as blood
sampling for liver function, alcohol markers and urine
sampling for alcohol markers. Besides data on rehabili-
tation, readmissions, ED, general practitioners, specialist
doctor, physiotherapist and occupational therapist, alcohol
treatment services, nursing home, community nurse, home
care, return to work and/or previous activity level, anduse of medicines will be collected at all follow-up
points.
All personal research data will be handled confiden-
tially and anonymously after collection in the case report
files. Only the study identification number and no per-
sonal identification data will be entered in the research
database.
Cost data
Data is collected for each individual patient in the pro-
ject. The hospital costs will be based on the initial emer-
gency room visits, the hospital stay in the orthopaedic
surgical ward or intensive care units, readmissions and
outpatient visits in the 12 months follow-up period. The
costs related to the Scand-Ankle trial, including the pro-
ject visits for outpatients, will be categorised as either
GSP-A-related costs (staff salaries) or extra project costs
(such as extra laboratory tests, medications and transpor-
tation). The costs related to primary care and other health
care sectors will be derived from the consultation fees for
general practitioners and “doctors on call”, average wages
for specialists, home helpers, day care nurses, etc.
Intervention
Patients allocated to the intervention group receive the
GSP-A aiming at alcohol abstinence before, during and
6 weeks after surgery. The intervention will be initiated
after the baseline interview has been completed and is
conducted by research staff. To qualify for the interven-
tion research personnel has to take part in a 2-day edu-
cational programme followed by practical training. The
GSP-A consists of weekly intervention meetings at the
orthopaedic ward or outpatient clinic (5 in total); see
Table 1.
The structured patient education programme covers
different topic at each meeting. At the first meeting, the
patients will receive further information on the associ-
ation between alcohol intake and postoperative compli-
cations. They will also be tested for ambivalence and
level of motivation using different motivation scales to
support patients’ empowerment: the LINE (see Table 2),
the BOX (see Table 3) and the CIRCLE (see Figure 2)
[39,40].
The education topic at the second meeting focuses on
dependence and withdrawal symptoms with a particular
focus on experiences and conceptions. The patients may
develop stress caused by abstinence from alcohol. The
withdrawal stress response is reduced by offering support-
ive medical treatment against development of mild to
moderate withdrawal symptoms (minor doses of chlordi-
azepoxide), while severe alcohol withdrawal symptoms are
treated in accordance with the recommendations and clin-
ical guidelines from the psychiatric department related to
the hospital. The personal stress is expected to be reduced
Table 1 Gold standard programme for alcohol cessation
intervention
Patient education programme
1. First meeting (during admission): Level of motivation,
ambivalence, pros and cons
2. Second meeting (after 1 week): Dependence, withdrawal
symptoms (experiences and expectations)
3. Third meeting (after 2 weeks): Relapse (description and management)
4. Fourth meeting (after 3 weeks): Benefits by short and
long term alcohol abstinence
5. Fifth meeting (after 4 weeks): Continued alcohol abstinence
or reduced intake following intervention
At each meeting
• Thiamine and B-vitamins (300 mg × 7 weekly)
• Alcohol withdrawal prophylaxis and treatment (chlordiazepoxid 10 mg)
• DIS support (200 mg × 2 weekly) supervised at weekly meetings
(not administrated if patients test positive on an alcohol breath test)
• Alcohol biomarkers (blood, urine and breath tests)
• ECG
The study medication is provided for free and transportation for the weekly
meetings will be reimbursed. Patients can also contact the research personnel
via phone or e-mail.
Table 3 The BOX for assessingambivalence
What are the advantages
of keep drinking alcohol?
What are the disadvantages
of keep drinking alcohol?
What are the disadvantages
of giving up alcohol?
What are the advantages of
giving up alcohol?
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third meeting the focus is on relapse management and sit-
uations, where it is most likely that the patients will feel
like drinking again. In case of relapse, the aim is to focus
on the experiences the patients have gained while being
abstinent and use these to initiate a new change and sup-
port the patients to resume abstinence. The patients are
encouraged to participate in all meetings whether they
comply with intervention or not. At the fourth meeting
other benefits of short- and long-term alcohol abstinence
is discussed with the patients, and at the last meeting the
patients are encouraged to either continued alcohol ab-
stinence after the 6-week intervention period (especially
for patients who have experienced withdrawal symptoms),
or if they do not want to be abstinent to keep their intake
at a non-hazardous level. Following the intervention theTable 2 The LINE for identification
Information - All operations can cause complications, but many
complications can be prevented. An important part of
the prevention is your own effort as well as the support
from the hospital.
Question 1:
- How important is it for you to prevent complications
in relation to your surgery – on a scale from 0 to 10?
Information - Hazardous drinking patients have 3 to 4 times more
complications than others.
Question 2:
- How important is it for you to stop drinking alcohol in
relation to your operation – on a scale from 0 to 10?patients can be referred to outpatient alcohol treatment
facilities on their request.
Control
Patients allocated to the control group receive standard
care for patients with hazardous alcohol intake undergo-
ing ankle fracture surgery including surveillance/scoring
for alcohol withdrawal symptoms and related treatment
according to the clinical guidelines in the wards. The
standard procedures regarding alcohol are often non-
interventional and characterised by short information
and advices about changing alcohol habits. All control
patients are informed about the possibility for alcohol
intervention in their neighbourhood by delivery of a
folder.
All patients
Both groups receive routine procedures regarding general
patient information, thromboembolic prophylaxis and
antibiotics, anaesthesia, surgical intervention and other
procedures according to the clinical guidelines for the
operation at the involved wards. All patients have ben-
zodiazepines for pre-medication. Sufficient thiamine is
administered prior to eventual infusion of glucose.
In case of incidental findings all necessary steps would
be taken for related information, diagnosing, intervention
and follow-up. Severely dependent patients, including pre-
vious alcohol withdrawal symptoms, are not included in
the study, but are referred to conventional treatment and
observation according to national and international clin-
ical guidelines.
Measures
The primary and secondary outcomes will be evaluated
at follow-up points after 6 weeks, 3, 6, 9 and 12 months.
Primary outcomes
 Postoperative minor and major complications
requiring treatment: Wound complications,
dislocated fracture, mal-union and secondary
surgery and others such as pneumonia, thrombosis
and neurological complications. Postoperative
complications will be evaluated by an orthopaedic
specialist blinded to patients’ group allocation.
 Continuous alcohol abstinence and non-hazardous
drinking validated biochemically
 Cost-effectiveness
Figure 2 The stages of change model.
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The secondary outcomes include length of stay, recon-
valescense (time until returning to work), self-evaluated
health (SF36), degree of alcohol withdrawal symptoms
and cost-effectiveness regarding changes in health-related
quality of life (QALY [41]).
Sample size
Sample size calculations are restricted by this being the
first study evaluating the effect of alcohol cessation in-
tervention in acute fracture surgery, and the number of
patients needed differ depending on the outcome.
The effect on alcohol abstinence is based on the pre-
operative intensive alcohol interventions, which showed
a very high effect above 90% in the intervention groups
versus less than 10% in the control groups [16]. How-
ever, a more moderate effect is expected in acute frac-
ture surgery with 50% abstainers in the GSP-A group
after 6 weeks. This corresponds to a minimum of 2×12
patients.Postoperative complication rates among ankle fracture
patients were 30% for patients drinking at least 5 drinks
per day versus 10% in patients without hazardous alco-
hol intake in a case-control study [42]. If similar compli-
cation rates after 6 weeks are expected in the control
and GSP-A group respectively, a total maximum of 2×59
patients should be recruited over the 3 to 4 years inclu-
sion period.
The number of patients for the cost-effectiveness
analyses is based on the expected effect on the clinical
outcomes [43].
All sample size calculations are based on a power of
80% and a risk of type 1 failure on 5%. Also to reduce
differences between patient populations, each centre
should include about 20 patients.
Statistical analyses
The analyses will be performed blinded. The groups are
compared regarding primary and secondary outcomes
using Chi-square/Fisher’s exact test for frequencies and
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will be conducted using intention-to-treat principles. A
p-value < 0.05 is considered statistically significant. Sub-
group analyses for determination of prognostic factors
are done through logistic regression analyses.
The cost-effectiveness of the GSP-A will be estimated
by comparing the incremental cost to the incremental
effect of the two groups. The GSP-A is considered more
cost-effective than standard care if it is less costly and
more effective. If the GSP-A is more costly and more ef-
fective, the additional cost per abstainer has to be con-
sidered worth paying [44].
Data will be analysed using IBM SPSS v. 19 and Excel
2010.
Project status
Patient inclusion was finalised in 2014. A few patients
are still in the follow-up process, and the analysis of short-
term outcomes is still ongoing. The study is supposed to
be completed by the end of 2015.
Discussion
The overall aim of the Scand-Ankle project is to contrib-
ute to the development of evidence-based guidelines for
perioperative alcohol cessation interventions, and this is
the first study to evaluate the effect of a new comprehen-
sive GSP-A on postoperative complications, alcohol intake
and cost-effectiveness in acute fracture surgery.
A recent study shows that hazardous drinking patients
with ankle fracture still have a very high complication rate
(personal communications Aalykke et al.) similar to the
rates used for the sample size calculation for this trial.
Strengths and limitations
The randomised design provides evidence on the highest
possible level regarding the effect of alcohol cessation
intervention in acute fracture surgery. Blinding of pa-
tients and project staff is not possible or intended as the
GSP-A includes patient education to support abstinence.
However, evaluation of postoperative complications is
performed blinded by an orthopaedic specialist unaware
of the patients’ group allocation. Also, the statistical ana-
lyses are done blinded by an independent researcher.
Recruitment of patients to the trial is expected to be
difficult, as the number needed to screen (NNS) to iden-
tify and include eligible patients may be very high. The
NNS to get one eligible to accept participation in alcohol
intervention studies varies from a few up to 70 patients
[13]. The rates do not differ between RCTs and non-
RCTs, or between brief and intensive alcohol intervention
studies. Also, in a study on smoking cessation intervention
in acute fracture surgery 61% of the eligible patients de-
clined to participate [45]. Finally, recruitment rates may
also vary between countries and/or centres.Perspectives
The study provides new knowledge about alcohol treat-
ment and how to prevent alcohol-related postoperative
complications as well as cost-effectiveness of these at the
time of acute fracture surgery. From a clinical perspec-
tive this may help to improve the perioperative course.
At the same time it will be necessary to address hazard-
ous drinking among patients in acute fracture surgery,
and thus also a need for systematic identification of alco-
hol intake, more detailed patient information as well as
better education of staff. For the patients a shorter
period of alcohol abstinence could be a positive experi-
ence and may also initiate a general reduction in hazard-
ous drinking, which will be a benefit on long term. Also,
the prospect of fewer complications is important from
the patient perspective. For the society an optimised
postoperative course, decreased use of health care re-
sources and fewer sick days will induce immediate cost-
savings, and in addition, fewer alcohol-related problems
will also benefit society.
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